Intravitreal micronized triamcinolone versus triamcinolone acetonide: A clinical and morphological comparative study

International Journal of Immunopathology and Pharmacology

Volumn 21, Issue 1, 2008, Pages 181-188

  Salvolini, Eleonora ^a   Neri, P ^a   Orciani, M ^a   Di Primio, R ^a   Giovannini, A ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

BIO score; Intraocular pressure; Intravitreal triamcinolone acetonide; Micronized triamcinolone; Rabbits; SEM

Indexed keywords

TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG SAFETY; ENDOPHTHALMITIS; ENUCLEATION; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; NONHUMAN; OPHTHALMOSCOPY; PRIORITY JOURNAL; RABBIT;

EID: 41849150398     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200802100120     Document Type: Article

References (27)

1. Machemer R., G. Sugita and Y. Tano. 1979. Treatment of intraocular proliferations with intravitreal steroids. Trans. Am. Ophthalmol. Soc. 77:171.
2. Tano Y., D. Chandler and R. Machemer. 1980. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am. J. Ophtalmol. 90:810.
3. Antcliff R.J., D.J. Spalton, M.R. Stanford, E.M. Graham, T.J. Ffytche and J. Marshall. 2001. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 108:765.
4. Degenring R.F., B. Kamppeter, I. Kreissig and J.B. Jonas. 2003. Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion. Acta Ophthalmol. Scand. 81: 399.
5. Beer P.M., S.J. Bakri, R.J. Singh, W. Liu, G.B. Peters III and M. Miller. 2003. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 110: 681.
6. Jonas J.B., R. Degenring, B. Kamppeter, I. Kreissig and I. Akkoyun. 2004. Duration of the effect of intravitreal triamcinolone acetonide as treatment of diffuse diabetic macula oedema. Am. J. Ophthalmol. 138: 158.
7. Jonas J.B. 2004. Intraocular availability of triamcinolone acetonide after intravitreal injection. Am. J. Ophthalmol. 137:560.
8. Gillies M.C., J.M. Simpson, F.A. Billson, W. Luo, P. Penfold, W. Chua, P. Mitchell, M. Zhu and A.B. Hunyor. 2004. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch. Ophthalmol. 122:336.
9. Kaushik S., V. Gupta, A. Gupta, M.R. Dogra and R. Singh. 2004. Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion. Am. J. Ophthalmol. 137:758.
10. Nelson M.L., M.T. Tennant, A. Sivalingam, G.D. Regillo, J.B. Belmont and A. Martidis. 2003. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 23:686.
11. Degenring R.F. and J.B. Jonas. 2004. Serum levels of triamcinolone acetonide after intravitreal injection. Am. J. Ophthalmol. 137:1142.
12. Singh I.P., S.I. Ahmad, D. Yeh, P. Challa, L.W. Herndon, R.R. Allingham and P.P. Lee. 2004. Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection. Am. J. Ophthalmol. 138:286.
13. Kai W., J. Yanrong and L. Xiaoxin. 2006. Vehicle of triamcinolone acetonide is associated with retinal toxicity and transient increase of lens density. Graefe's Arch. Clin. Exp. Ophthalmol. 244:1152.
14. Jonas J.B. 2005. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Acta Ophthalmol. Scand. 83:645.
15. Parke D.W. 2003. Intravitreal triamcinolone and endophthalmitis. Am. J. Ophthalmol. 136:918.
16. Roth D.B., J. Chieh, M.J. Spim, S.N. Green, D.L. Yarian and N.A. Chaundry. 2003. Non-infectious endophthalmitis associated with intravitreal triamcinolone injection. Arch. Ophthalmol. 121: 1279.
17. McCuen B.W. 2nd, M. Bessler, Y. Tano, D. Chandler and R. Machemer. 1981. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am. J. Ophthalmol. 91:785.
18. Jonas J.B., R. Degenring and I. Kreissig. 2004. Safety of intravitreal high-dose reinjections of triamcinolone acetonide. Am. J. Ophthalmol. 138: 1054.
19. Yeung C.K., K.P. Chan, C.K. Chan, C.P. Pang and D.S. Lam. 2004. Cytotoxicity of triamcinolone on cultured human retinal pigment epithelial cells: comparison with dexamethasone and hydrocortisone. Jpn. J. Ophthalmol. 48:236.
20. Yeung C.K., K.P. Chan, S.W. Chiang, C.P. Pang and D.S. Lam. 2003. The toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinolone. Invest. Ophthalmol. Vis. Sci. 44:5293.
21. Zemel E., A. Loewenstein, B. Lei, M. Lazar and I. Perlman. 1995. Ocular pigmentation protects the rabbit retina from gentamicin-induced toxicity. Invest. Ophthalmol. Vis. Sci. 36:1875.
22. Schindler R.H., D. Chandler, R. Thresher and R. Machemer. 1982. The clearance of intravitreal triamcinolone acetonide. Am. J. Ophthalmol. 93: 415.
23. Bloch-Michel E. and R.B. Nussenblatt. 1987. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory diseases. Am. J. Ophthalmol. 103:234.
24. The standardization of uveitis nomenclature (SUN) working group. 2005. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am. J. Ophthalmol. 140:509.
25. Hida T., D. Chandler, J.E. Arena and R. Machemer. 1986. Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am. J. Ophthalmol. 101:190.
26. Morrison V.L., H.J. Koh, L. Cheng, K. Bessho, M.C. Davidson and W.R. Freeman. 2006. Intravitreal toxicity of the Kenalog vehicle (benzyl alcohol) in rabbits. Retina 26:339.
27. Yu S.Y., F.M. Damico, F. Viola, D.J. D'Amico and L.H. Young. 2006. Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study. Retina 26:531.